Phase I/II trial of Multitope peptide based vaccine - COVAXX
Latest Information Update: 20 Jul 2020
At a glance
- Drugs UB 612 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors COVAXX
- 20 Jul 2020 New trial record
- 15 Jul 2020 According to a COVAXX media release, it is also filing an IND with the U.S. FDA to initiate clinical trials this fall in the U.S. in collaboration with the University of Nebraska Medical Center (UNMC) as its core site for its Phase I/II trial.